← Browse by Condition
Medical Condition

neoplasms squamous cell

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05252078 Phase 2
Recruiting

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
View Trial →